PRNewsWire
18 Nov 2025, 00:39 UTC · 44w ago
Verdict
Headline leans bearish. We score CYTK −1.00.
Score confirms the headline.
Leans bearish
From its wording — no explicit rating
−1.00strongly bearish
Which stocks this story touches
More negative than 95% of ticker scores this week
The company is facing a securities fraud class action lawsuit alleging misleading statements regarding FDA approval timelines.
More negative than 77% of ticker scores this week
The company is mentioned as being under investigation for potential securities claims by the Rosen Law Firm.
Continue reading
5 related stories
More negative than 95% of ticker scores this week
Scored by the NIS engine · methodology.
Top 3 movers · tap to explore
Read next
Newsfile Corp · 6h ago
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
MarketBeat
14h ago
−2.7%
Price agrees with the score
$65.14 vs $66.95 close before publication (Nov 17) · not market-adjusted
CYTK chart →
